-
1
The impact of sofosbuvir/ledipasvir on chronic hepatitis C-infected paediatric patients: a Middle East single-centre experience
Published 2023-11-01Subjects: Get full text
Article -
2
Clinical, Virological Characteristics, and Outcomes of Treatment with Sofosbuvir/Ledipasvir in Two Pediatric Patients Infected by HCV Genotype 4
Published 2019-05-01Subjects: Get full text
Article -
3
High sustained virological response rates using imported generic direct acting antiviral treatment for hepatitis C
Published 2017-10-01Subjects: “…hepatitis C, direct acting antivirals, sofosbuvir, ledipasvir, daclatasvir…”
Get full text
Article -
4
Early sofosbuvir-ledipasvir treatment for acute HCV infection induced severe immune thrombocytopenia – a case report
Published 2018-12-01Subjects: Get full text
Article -
5
Sofosbuvir/ledipasvir safety and efficacy for HCV patients with haemodialysis and liver cirrhosis: a small retrospective study
Published 2021-10-01Subjects: Get full text
Article -
6
Simultaneous chromatographic analysis of Sofosbuvir/Ledipasvir in their combined dosage form: an application to green analytical chemistry
Published 2019-12-01Subjects: “…Sofosbuvir/ledipasvir…”
Get full text
Article -
7
-
8
-
9
Living donor domino liver transplantation in a hepatitis C virus/human immunodeficiency virus-coinfected hemophilia patient: a case report
Published 2020-07-01Subjects: Get full text
Article -
10
Cost-Effectiveness Analysis of Pan-Genotypic Sofosbuvir-Based Regimens for Treatment of Chronic Hepatitis C Genotype 1 Infection in China
Published 2021-12-01Subjects: Get full text
Article -
11
Combination of Sofosbuvir-Ledipasvir and Sofosbuvir- Daclatasvir for Treatment HCV Patients in Indonesia
Published 2023-12-01Subjects: Get full text
Article -
12